| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |